top of page

Precision Testing,
Ensuring Health

Products and Services

Next Generation Genetic Testing

The ACCUiN Next Generation Cancer Gene Analysis Panel is designed using multiplex PCR and next-generation sequencing (NGS) technology to detect the presence of somatic cell mutations in formalin-fixed paraffin-embedded malignant solid tumor tissues (FFPE) and is suitable for lung cancer, breast cancer, colorectal cancer, and gastric stromal cancer.

Disease Risk Genetic Testing

Our disease risk genetic testing kits are designed specifically for testing laboratories and health management centers, assisting you in providing rapid and accurate genetic disease risk assessments for the individuals. The ACCUiN disease risk genetic testing kits are applicable to multiple disease categories, including elderly care, nutritional absorption, cardiovascular health, and autoimmunity.

Newborn/Preconception Genetic Testing

ACCUiN newborn/preconception genetic testing kits are designed using various biotechnologies, including polymerase chain reaction (PCR), real-time PCR, capillary electrophoresis (CE), and sequencing technologies. Our product range includes genetic testing for Fragile X syndrome, hereditary hemochromatosis, thalassemia, Huntington's disease, and other genetic conditions. ACCUiN newborn/preconception genetic testing kits are ideal for couples planning to conceive, expectant mothers, and newborns.

Pathogen/Infectious Disease Detection

Our pathogen/infectious disease detection kits provide testing laboratories, medical institutions, and research organizations with rapid, efficient, and reliable tools for pathogen detection, helping you make accurate diagnostic and treatment decisions in the shortest possible time.

Automated Analysis Software

ACCUiN automated analysis software are designed for use with ACCUiN genetic testing kits/panels, supporting data analysis from technologies such as polymerase chain reaction (PCR), real-time PCR, capillary electrophoresis (CE), sequencing, and next generation sequencing (NGS). Our software provides an all-in-one data analysis solution for laboratories specializing in genomics, oncology, and pathogen detection, simplifying complex analytical processes into an efficient and streamlined workflow.

Laboratory Certification Service

A comprehensive screening tool designed specifically for newborns that can detect a variety of genetic diseases and metabolic disorders. This kit helps doctors detect potential health problems early and provide timely treatment and care for babies.

Our story

ACCUiN Biotech was founded in 2021, focusing on Next Generation Sequencing (NGS) technology as its core, and is dedicated to developing high-quality NGS reagents and analysis software. Since its inception, the company has concentrated on the NGS field. With a professional team and continuous technological innovation, it has quickly become one of the leaders in this field. Our main products include:

  • NGS reagent kits with high sensitivity and accuracy, covering the entire workflow from DNA/RNA extraction to library preparation and sequencing

  • Fast and efficient NGS data analysis software, providing integrated solutions from raw data to bioinformatics analysis

Based on years of technological accumulation and industry experience, our products lead the industry in key indicators such as accuracy, sensitivity, and stability. They are widely applied in clinical testing, basic research, drug development, and other fields. We have always adhered to a customer-oriented approach, continuously optimizing product performance and improving user experience. At the same time, we place great importance on talent cultivation, having established a comprehensive training system to provide employees with broad career development opportunities.

Healthcare by ACCUrate INspection

8F.-3, No. 192, Ruiguang Rd., Neihu Dist.,

Taipei City 111466 , Taiwan

Tel: +886-2-27949405

  • LinkedIn
  • GitHub

©2024 by ACCUiN BioTech.

bottom of page